Featured Research

from universities, journals, and other organizations

Genetically Engineered Poliovirus Fights Brain Tumors

Date:
May 22, 2001
Source:
American Society For Microbiology
Summary:
What do you get when you cross a poliovirus with the virus that causes the common cold? An efficient mechanism for killing brain tumors, say scientists at Duke University, who have successfully used the genetically modified poliovirus to cure brain tumors in mice.

What do you get when you cross a poliovirus with the virus that causes the common cold? An efficient mechanism for killing brain tumors, say scientists at Duke University, who have successfully used the genetically modified poliovirus to cure brain tumors in mice. They report their results at the 101st General Meeting of the American Society for Microbiology.

Related Articles


"Malignant glioma (the most common type of brain tumor) is almost always fatal, due to very poor response to surgery, radiation and chemotherapy," says Matthias Gromeier, in whose laboratory the research was conducted. "We have developed a new form of therapy against malignant glioma based on viruses that can cause brain infections in humans."

The creation of this new therapy began when Gromeier and his colleagues discovered that the molecule that the poliovirus binds to on human cells, CD155, is abnormally expressed on malignant gliomas. This meant that the poliovirus would naturally target brain tumors. Unfortunately, the use of the virus as a treatment was severely limited by its ability to cause polio in humans.

"We genetically engineered a poliovirus variant that lost its ability to cause disease in humans. We accomplished this task by inserting a piece of genetic information of rhinovirus (the virus that causes the common cold) into the poliovirus genome," says Gromeier. "The mixed polio/rhinovirus construct had very surprising properties: it had lost its ability to cause poliomyelitis in humans, but retained excellent killing potential for malignant glioma cells."

They tested the abilities of this new hybrid virus using mice with experimental brain tumors. The animals recovered after a single dose of the virus. "Pathological analysis of their brains revealed tumors to be eliminated by replicating virus within days," says Gromeier.

This research was conducted with support from the American Cancer Society, the National Cancer Institute and the Burroughs Wellcome Fund.


Story Source:

The above story is based on materials provided by American Society For Microbiology. Note: Materials may be edited for content and length.


Cite This Page:

American Society For Microbiology. "Genetically Engineered Poliovirus Fights Brain Tumors." ScienceDaily. ScienceDaily, 22 May 2001. <www.sciencedaily.com/releases/2001/05/010522073358.htm>.
American Society For Microbiology. (2001, May 22). Genetically Engineered Poliovirus Fights Brain Tumors. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/2001/05/010522073358.htm
American Society For Microbiology. "Genetically Engineered Poliovirus Fights Brain Tumors." ScienceDaily. www.sciencedaily.com/releases/2001/05/010522073358.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins